Risk assessment tools for detecting those with pre-diabetes: a systematic review.

AIM To describe and evaluate risk assessment tools which detect those with pre-diabetes defined as either impaired glucose tolerance or impaired fasting glucose using an OGTT or as a raised HbA1c. METHODS Tools were identified through a systematic search of PubMed and EMBASE for articles which developed a risk tool to detect those with pre-diabetes. Data were extracted using a standardised data extraction form. RESULTS Eighteen tools met the inclusion criteria. Eleven tools were derived using logistic regression, six using decision trees and one using support vector machine methodology. Age, body mass index, family history of diabetes and hypertension were the most frequently included variables. The size of the datasets used and the number of events per variable considered were acceptable in all the tools. Missing data were not discussed for 8 (44%) of the tools, 10 (91%) of the logistic tools categorised continuous variables, external validation was carried out for only 7 (39%) of the tools and only 3 tools reported calibration levels. CONCLUSIONS Several risk scores are available to identify those with pre-diabetes. Before these are used in practice, the level of calibration and validity of the tools in the population of interest should be assessed.

[1]  K. Maurer,et al.  Third national health and nutrition examination survey , 1985 .

[2]  Wei-Yin Loh,et al.  Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..

[3]  David Madigan,et al.  Discussion of "Least angle regression" by Efron et al , 2004 .

[4]  Thomas G. Dietterich An Experimental Comparison of Three Methods for Constructing Ensembles of Decision Trees: Bagging, Boosting, and Randomization , 2000, Machine Learning.

[5]  Maarten Keijzer,et al.  Development and validation of clinical prediction models: marginal differences between logistic regression, penalized maximum likelihood estimation, and genetic programming. , 2012, Journal of clinical epidemiology.

[6]  J. Ross Quinlan,et al.  C4.5: Programs for Machine Learning , 1992 .

[7]  Nicola J Cooper,et al.  Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[8]  Risk scores for diabetes and impaired glycaemia in the Middle East and North Africa , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[9]  V. Vaccarino,et al.  Glucose challenge test screening for prediabetes and undiagnosed diabetes , 2009, Diabetologia.

[10]  J. Shaw,et al.  International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.

[11]  G. Collins,et al.  Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting , 2011, BMC medicine.

[12]  Ewout W Steyerberg,et al.  Internal and external validation of predictive models: a simulation study of bias and precision in small samples. , 2003, Journal of clinical epidemiology.

[13]  Douglas G Altman,et al.  Dichotomizing continuous predictors in multiple regression: a bad idea , 2006, Statistics in medicine.

[14]  J. Shaw,et al.  Global estimates of diabetes prevalence for 2013 and projections for 2035. , 2014, Diabetes Research and Clinical Practice.

[15]  K. Khunti,et al.  Let’s prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation , 2012, Cardiovascular Diabetology.

[16]  E. Boyko,et al.  Predicting impaired glucose tolerance using common clinical information: data from the Third National Health and Nutrition Examination Survey. , 2003, Diabetes care.

[17]  K. Khunti,et al.  Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting , 2012, Diabetologia.

[18]  Muin J. Khoury,et al.  Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes , 2010, BMC Medical Informatics Decis. Mak..

[19]  David L. Cassell,et al.  Stopping stepwise: Why stepwise and similar selection methods are bad, and what you should use , 2007 .

[20]  Alan J. Miller Subset Selection in Regression , 1992 .

[21]  David Newby,et al.  Survey of diabetes risk assessment tools: concepts, structure and performance , 2012, Diabetes/metabolism research and reviews.

[22]  David M. Eddy,et al.  Diabetes Risk Calculator , 2008, Diabetes Care.

[23]  Jin-Kui Yang,et al.  A simple tool detected diabetes and prediabetes in rural Chinese. , 2010, Journal of clinical epidemiology.

[24]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[25]  Trisha Greenhalgh,et al.  Risk models and scores for type 2 diabetes: systematic review , 2011, BMJ : British Medical Journal.

[26]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[27]  Simon J. Griffin,et al.  Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes , 2011, Epidemiologic reviews.

[28]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[29]  Alberto Maria Segre,et al.  Programs for Machine Learning , 1994 .

[30]  Cynthia Balion,et al.  Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. , 2007, Diabetes research and clinical practice.

[31]  R. Koopman,et al.  Tool to Assess Likelihood of Fasting Glucose ImpairmenT (TAG-IT) , 2008, The Annals of Family Medicine.

[32]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[33]  Karel G M Moons,et al.  Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study , 2012, BMJ : British Medical Journal.

[34]  J. Critchley,et al.  Risk scores based on self-reported or available clinical data to detect undiagnosed type 2 diabetes: a systematic review. , 2012, Diabetes research and clinical practice.

[35]  K. Khunti,et al.  Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis , 2013, Diabetologia.

[36]  M. Fowler Microvascular and Macrovascular Complications of Diabetes , 2008, Clinical Diabetes.

[37]  K. Khunti,et al.  A comparison of cost per case detected of screening strategies for Type 2 diabetes and impaired glucose regulation: modelling study. , 2012, Diabetes research and clinical practice.

[38]  L. Strunin,et al.  Using Resident Health Advocates to Improve Public Health Screening and Follow-Up Among Public Housing Residents, Boston, 2007-2008 , 2010, Preventing chronic disease.

[39]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[40]  W. G. John,et al.  Use of haemoglobin A1c (HbA1c) in the diagnosis of diabetes mellitus. The implementation of World Health Organisation (WHO) guidance 2011 , 2012 .

[41]  E. Steyerberg,et al.  Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research , 2013, PLoS medicine.

[42]  K. Khunti,et al.  The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[43]  Joachim Selbig,et al.  Decision trees as a simple-to-use and reliable tool to identify individuals with impaired glucose metabolism or type 2 diabetes mellitus. , 2010, European journal of endocrinology.

[44]  R. Hamman,et al.  Population screening for glucose intolerant subjects using decision tree analyses. , 1996, Diabetes research and clinical practice.

[45]  K. DuBose,et al.  Development and Validation of a Tool for Assessing Glucose Impairment in Adolescents , 2012, Preventing chronic disease.

[46]  G. Agarwal,et al.  Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population. , 2011, Chronic diseases and injuries in Canada.

[47]  Leo Breiman,et al.  Classification and Regression Trees , 1984 .